CliffBio
small molecule

RENAMIN W/O ELECTROLYTES

AMINO ACIDS

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameRENAMIN W/O ELECTROLYTES
Active ingredientAMINO ACIDS
Strength6.5% (6.5GM/100ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalOctober 1982
Marketing statusDISCN

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.